Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Scleroderma, Systemic

n(g),n(g')-dimethyl-l-arginine has been researched along with Scleroderma, Systemic in 11 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research Excerpts

ExcerptRelevanceReference
" The aim of this study was to examine associations between asymmetric dimethylarginine (ADMA) - a biomarker of atherosclerosis - and assessments of macrovascular endothelial function in patients with SSc."4.31The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study. ( Dimitroulas, T; Doumas, M; Garyfallos, A; Karagiannis, A; Katsiki, N; Kitas, G; Loutradis, C; Malliari, A; Pagkopoulou, E; Soulaidopoulos, S, 2023)
" While there is no established dosing regimen, studies of oral l-arginine in secondary RP suggest that divided dosing may begin at 1-2 g/day and may be titrated up to 10 g/day."2.61The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon. ( Curtiss, P; Franks, AG; Lo Sicco, K; Schwager, Z, 2019)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's5 (45.45)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Pagkopoulou, E2
Soulaidopoulos, S2
Triantafyllidou, E1
Loutradis, C2
Malliari, A2
Kitas, GD1
Garyfallos, A3
Dimitroulas, T4
Katsiki, N1
Karagiannis, A1
Doumas, M1
Kitas, G1
Curtiss, P1
Schwager, Z1
Lo Sicco, K1
Franks, AG1
Ciurzyński, M1
Bienias, P1
Irzyk, K1
Kostrubiec, M1
Bartoszewicz, Z1
Siwicka, M1
Stelmaszczyk-Emmel, A1
Górska, E1
Demkow, U1
Pruszczyk, P1
Zhang, L1
Wan, YN1
Zhao, JH1
Wang, YJ1
Wang, YX1
Yan, JW1
Huang, XL1
Wang, J1
Blaise, S1
Maas, R1
Trocme, C1
Kom, GD1
Roustit, M1
Carpentier, PH1
Cracowski, JL1
Giannakoulas, G2
Papadopoulou, K2
Karvounis, H2
Dimitroula, H2
Koliakos, G2
Karamitsos, T1
Parcharidou, D2
Settas, L2
Sfetsios, T1
Styliadis, I1
Dooley, A1
Gao, B1
Bradley, N1
Abraham, DJ1
Black, CM1
Jacobs, M1
Bruckdorfer, KR1
Wipff, J1
Avouac, J1
Borderie, D1
Zerkak, D1
Lemarechal, H1
Kahan, A1
Boileau, C1
Allanore, Y1
Lischwe, MA1
Ochs, RL1
Reddy, R1
Cook, RG1
Yeoman, LC1
Tan, EM1
Reichlin, M1
Busch, H1

Reviews

2 reviews available for n(g),n(g')-dimethyl-l-arginine and Scleroderma, Systemic

ArticleYear
The clinical effects of l-arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:3

    Topics: Arginine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Raynaud Disease; Scleroderma, System

2019
The association between systemic sclerosis, arginine and asymmetric dimethylarginine.
    Inflammation, 2015, Volume: 38, Issue:1

    Topics: Animals; Arginine; Case-Control Studies; Humans; Nitric Oxide; Scleroderma, Systemic

2015

Other Studies

9 other studies available for n(g),n(g')-dimethyl-l-arginine and Scleroderma, Systemic

ArticleYear
Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis.
    Microvascular research, 2023, Volume: 145

    Topics: Adult; Aged; Capillaries; Cross-Sectional Studies; Female; Humans; Male; Microcirculation; Microscop

2023
The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.
    Clinical rheumatology, 2023, Volume: 42, Issue:4

    Topics: Adult; Aged; Arginine; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Cross-Sectional

2023
Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
    Clinical rheumatology, 2014, Volume: 33, Issue:1

    Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Case-Control Studies; Collagen; Echocardiography; E

2014
Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis.
    The Journal of rheumatology, 2009, Volume: 36, Issue:5

    Topics: Arginine; Biomarkers; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Matrix; Female; Humans

2009
Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
    The Journal of rheumatology, 2010, Volume: 37, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Flow Velocity; Echocardiography, Doppler; Endothe

2010
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
    Clinical rheumatology, 2010, Volume: 29, Issue:9

    Topics: Aged; Arginine; Biomarkers; Blood Pressure; Cross-Sectional Studies; Female; Follow-Up Studies; Hear

2010
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:6

    Topics: Adult; Arginine; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Mi

2006
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
    Rheumatology (Oxford, England), 2008, Volume: 47, Issue:7

    Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Cross-Sectional Studies; Endoglin; Female; Humans;

2008
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine.
    The Journal of biological chemistry, 1985, Nov-15, Volume: 260, Issue:26

    Topics: Amino Acid Sequence; Amino Acids; Animals; Antigens; Arginine; Autoantibodies; Cell Nucleolus; Fluor

1985